Taiho Oncology, Inc. works urgently to discover and develop innovative cancer treatments. As cancer evolves, we evolve with it—bringing novel technology to cornerstone chemotherapies, while at the same time optimizing new targeted agents. Advanced technology, dedicated investigators, and incomparable facilities—these vast resources empower us to redefine the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy.
The Compliance Officer (“CO”) is a member of the senior staff, reporting to the Vice President and General Counsel with additional oversight by the CEO. The CO is responsible for managing an effective and credible compliance program that is consistent with current industry best practices and government guidance, e.g., the U.S. Sentencing Guidelines and HHS OIG Compliance Guidance for Pharmaceutical Manufacturers, i.e., “The Seven Elements”. The CO will develop and execute annual compliance programs, monitoring and reporting results of the compliance/ethics efforts of the company and provide guidance and recommendations to senior management on matters relating to compliance, with a focus and priority on commercial compliance considerations. Seeks opportunities and improve corporate compliance, including establishing strong working relationships by partnering with department/functional leaders so as to have a positive and productive relationship with compliance. Periodic presentations to the company’s Board of Directors will also be required. The CO is authorized to implement all necessary actions to ensure achievement of the objectives of an effective compliance program and to build and maintain a culture of compliance that enables the business to operate effectively while meeting government compliance standards for effectiveness.